{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:04Z","timestamp":1760060944316,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jsat.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T06:48:12Z","timestamp":1389336492000},"page":"561-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland"],"prefix":"10.1016","volume":"46","author":[{"given":"Hanna","family":"Uosukainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni","family":"Ilom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Kauhanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"F\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2014.01.004_bb0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/0019-5545.70978","article-title":"Pattern of buprenorphine abuse among opioid abusers in Nepal","volume":"52","author":"Aich","year":"2010","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.01.004_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09595230123756","article-title":"Characteristics of regular amphetamine users and implications for treatment","volume":"20","author":"Baker","year":"2001","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2014.01.004_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jsp.2009.10.001","article-title":"An introduction to modern missing data analyses","volume":"48","author":"Baraldi","year":"2010","journal-title":"Journal of School Psychology"},{"key":"10.1016\/j.jsat.2014.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1360-0443.2000.95913637.x","article-title":"A longitudinal study of male buprenorphine addicts attending an addiction clinic in India","volume":"95","author":"Basu","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.01.004_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2014.01.004_bb0030","series-title":"A Guide to Training and Administering EuropASI Interviews","article-title":"European Addiction Severity Index (EuropASI)","author":"Blacken","year":"1994"},{"key":"10.1016\/j.jsat.2014.01.004_bb0035","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","article-title":"Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system","volume":"105","author":"Boscarino","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.01.004_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pain.2008.03.021","article-title":"Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse","volume":"139","author":"Cicero","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jsat.2014.01.004_bb0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.jsat.2014.01.004_bb0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1192\/bjp.185.3.196","article-title":"Stimulant psychosis: Systematic review","volume":"185","author":"Curran","year":"2004","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.01.004_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2014.01.004_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2014.01.004_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.puhe.2008.10.006","article-title":"Thinking the unthinkable: Could the increasing misuse of prescription opioids among street drug users offer benefits for public health?","volume":"123","author":"Fischer","year":"2009","journal-title":"Public Health"},{"key":"10.1016\/j.jsat.2014.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpain.2012.07.013","article-title":"The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: A systematic review and meta-analysis","volume":"13","author":"Fischer","year":"2012","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.jsat.2014.01.004_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.02.001","article-title":"Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009","volume":"109","author":"Fischer","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurpub\/12.3.228","article-title":"Heroin-assisted treatment as a response to the public health problem of opiate dependence","volume":"12","author":"Fischer","year":"2002","journal-title":"European Journal of Public Health"},{"key":"10.1016\/j.jsat.2014.01.004_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0376-8716(02)00323-X","article-title":"Predictors of follow-up health status in the drug abuse treatment outcome study (DATOS)","volume":"69","author":"Friedmann","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0095","doi-asserted-by":"crossref","first-page":"e27244","DOI":"10.1371\/journal.pone.0027244","article-title":"Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment","volume":"6","author":"Green","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jsat.2014.01.004_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.03.014","article-title":"Women who abuse prescription opioids: Findings from the addiction severity index-multimedia version connect prescription opioid database","volume":"103","author":"Green","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/15563650600981137","article-title":"Active surveillance of abused and misused prescription opioids using poison center data: A pilot study and descriptive comparison","volume":"45","author":"Hughes","year":"2007","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.jsat.2014.01.004_bb0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1360-0443.2004.00958.x","article-title":"Buprenorphine diversion and injection in Melbourne, Australia: An emerging issue?","volume":"100","author":"Jenkinson","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2014.01.004_bb0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00005053-199004000-00001","article-title":"Neurobiology of abused drugs. Opioids and stimulants","volume":"178","author":"Kosten","year":"1990","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2014.01.004_bb0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0740-5472(90)90035-O","article-title":"Depressive symptoms during buprenorphine treatment of opioid abusers","volume":"7","author":"Kosten","year":"1990","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2014.01.004_bb0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.clpt.6100503","article-title":"Potential of buprenorphine\/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders","volume":"83","author":"McCann","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jsat.2014.01.004_bb0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/09595230500290858","article-title":"Characteristics of treatment provided for amphetamine use in New South Wales, Australia","volume":"24","author":"McKetin","year":"2005","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2014.01.004_bb0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/a0027146","article-title":"Missing data in substance abuse treatment research: Current methods and modern approaches","volume":"20","author":"McPherson","year":"2012","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2014.01.004_bb0145","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2165\/11536020-000000000-00000","article-title":"Intravenous misuse of buprenorphine: Characteristics and extent among patients undergoing drug maintenance therapy","volume":"30","author":"Moratti","year":"2010","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.jsat.2014.01.004_bb0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1465-3362.2011.00302.x","article-title":"Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?","volume":"30","author":"Nielsen","year":"2011","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2014.01.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000253858","article-title":"Why do the clients of Georgian needle exchange programmes inject buprenorphine?","volume":"16","author":"Otiashvili","year":"2010","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2014.01.004_bb0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/00048674.2010.547455","article-title":"Amphetamine availability and admissions for psychosis in New South Wales, 2001-2009","volume":"45","author":"Sara","year":"2011","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2014.01.004_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2014.01.004_bb0170","article-title":"A five-year follow-up of buprenorphine abuse potential","volume":"1","author":"Simojoki","year":"2013","journal-title":"Alcoholism & Drug Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000018994","article-title":"The EMCDDA\/Pompidou Group treatment demand indicator protocol: A European core item set for treatment monitoring and reporting","volume":"5","author":"Simon","year":"1999","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2014.01.004_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003-2005","volume":"26","author":"Smith","year":"2007","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2014.01.004_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/10826080903452447","article-title":"The profile of injection drug users in Chennai, India: Identification of risk behaviours and implications for interventions","volume":"45","author":"Solomon","year":"2010","journal-title":"Substance use & Misuse"},{"key":"10.1016\/j.jsat.2014.01.004_bb0190","article-title":"Mortality among clients seeking treatment for buprenorphine abuse in Finland","author":"Uosukainen","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2012.07.002","article-title":"Twelve-year trend in treatment seeking for buprenorphine abuse in Finland","volume":"127","author":"Uosukainen","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0200","series-title":"National report to the EMCDDA by the Reitox Focal Point, National Institute for Health and Welfare, THL Report 76\/2012","article-title":"Finland Drug Situation 2012","author":"Varjonen","year":"2012"},{"key":"10.1016\/j.jsat.2014.01.004_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugalcdep.2010.03.014","article-title":"Injection of buprenorphine and buprenorphine\/naloxone tablets in Malaysia","volume":"111","author":"Vicknasingam","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2014.01.004_bb0210","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3109\/10826084.2012.690812","article-title":"Factors associated with drug-related psychiatric disorders and suicide attempts among illicit drug users in Taiwan","volume":"47","author":"Wang","year":"2012","journal-title":"Substance use & Misuse"},{"key":"10.1016\/j.jsat.2014.01.004_bb0215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.47102\/annals-acadmedsg.V35N7p451","article-title":"Socio-demographic profile and help-seeking behaviour of buprenorphine abusers in Singapore","volume":"35","author":"Winslow","year":"2006","journal-title":"Annals of the Academy of Medicine, Singapore"},{"key":"10.1016\/j.jsat.2014.01.004_bb0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2014.01.004_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"Journal of Addictive Diseases"},{"author":"World Health Organization","key":"10.1016\/j.jsat.2014.01.004_bb0230"},{"key":"10.1016\/j.jsat.2014.01.004_bb0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0b013e3181e0364e","article-title":"How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the national epidemiologic survey on alcohol and related conditions","volume":"5","author":"Wu","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2014.01.004_bb0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"},{"key":"10.1016\/j.jsat.2014.01.004_bb0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"Psychiatric symptoms in methamphetamine users","volume":"13","author":"Zweben","year":"2004","journal-title":"The American Journal on Addictions"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547214000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:39:57Z","timestamp":1760038797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547214000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0740547214000129"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2014.01.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2014.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}